SEC Form 4 · accession 0001610717-26-000195
10x Genomics, Inc. · TXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shehnaaz Suliman
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 7:26 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001770787
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jun 4, 2026 | A | 8,829 | $0.00 | A | 37,445 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date.
Remarks
Exhibit 24.1 - Power of Attorney